Zogenix' ZX008 Emerges As Strong Contender In Rare Epilepsy

12 Jul 2018

• By Emily Hayes

Strong efficacy and a clean safety profile – with no cardiovascular signal – in another Phase III study bode well for filings of Zogenix's ZX008 in the fourth quarter.

Epilepsy awareness concept. Brain and encephalography in epilepsy patient during seizure attack, 3D illustration in purple color — Brain and encephalography in epilepsy patient during seizure attack

Zogenix' ZX008 Emerges As Strong Contender In Rare Epilepsy

More from Archive

More from Scrip